Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
- PMID: 29527667
- DOI: 10.1111/bjh.15156
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
Keywords: bortezomib; chemotherapy; plasmablastic lymphoma; survival.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
